Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1995

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Decreasing the steroid dose in oral contraception and risk of functional

ovarian cysts. [Diminution des doses de steroides en contraception orale et

risque de kystes ovariens fonctionnels.]

AUTHORS

Mayenga JM; Segard L; Cohen J; Belaisch-Allart J

SOURCE

Contraception, Fertilite, Sexualite. 1995 Jul-Aug;23(7-8):439-41.

ABSTRACT

Reduction in steroids in combined oral contraceptives (OCs) in theory could lead to functional ovarian cysts. The

reduced dosage may lead to an insufficient inhibition of the pituitary gland, which in turn would cause

hyperestrogenemia. A literature review of low-dose OCs and ovarian cysts shows that researchers interested in the

incidence of ovarian cysts tend to be limited to isolated clinical cases and those found in a health facility without

conducting a prospective study. Studies still need to differentiate between ovarian follicles and real ovarian cysts.

Each study author knows that cases can have an unexpected or a persistent follicle even with normal-dose OCs.

Many authors suggest that only ovarian cysts greater than 40 mm in diameter and which have been proven to secrete

hormones should be considered functional ovarian cysts. Actual ovarian cysts can be obvious with all OCs.

Perhaps the 7% incidence ovarian cyst rate among low-dose OC users is the closest to reality. The physician needs

not to worry the patient and to block ovulation with normal-dose OCs or only progestogens for two months. If the cyst

disappears, low-dose OCs are contraindicated for the patient. If it persists, the physician should use classical

treatment to treat the ovarian cysts. Large prospective studies that consider evaluation criteria for residual ovarian

activity, ultrasound criteria, and hormonal criteria will yield the real incidence of ovarian cysts among users of low-

dose OCs. Until then, it is better to not speak about ovarian cysts less than 4 cm in diameter, not to worry patients,

and to switch to a normal dose OC in persistent cases of ovarian cysts. (PubHealth.info Document ID: CONT2T

2517-06)

PubHealth.info NOTE: The author(s) of this article titled, "Decreasing the steroid dose in oral contraception and risk

of functional ovarian cysts. [Diminution des doses de steroides en contraception orale et risque de kystes ovariens

fonctionnels.]", is(are) Mayenga JM; Segard L; Cohen J; Belaisch-Allart J. The source of this article is

"Contraception, Fertilite, Sexualite. 1995 Jul-Aug;23(7-8):439-41.". This article was published in 1995 in French

language(s). (PubHealth.info® Document ID: CONT2T 2517-06. All rights reserved with PubHealth.info) PIN: 7517

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.